Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates

Go back to Krystal Biotech Announces Third Quarter 2024 Financial Results and Provides Business Updates
(NASDAQ: KRYS) Delayed: 348.06 +6.40 (1.87%)
Previous Close $341.66    52 Week High
Open $350.00    52 Week Low
Day High $356.50    P/E N/A 
Day Low $343.48    EPS
Volume 811,433